Thoracic Aortic Aneurysm Market Size, Share & Trends Analysis Report By Treatment Type (Open Surgical Repair, Thoracic Endovascular Aneurysm Repair), By End User (Hospitals, Ambulatory Surgery Centers, Specialty Clinics) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Thoracic Aortic Aneurysm Market Size

The global thoracic aortic aneurysm market size was valued at USD 1.18 billion in 2025 and is projected to grow from USD 1.29 billion in 2026 to USD 2.56 billion by 2034, registering a CAGR of 8.98% during the forecast period from 2026 to 2034. North America dominated the thoracic aortic aneurysm market with a market share of 44.23% in 2025.

The thoracic aortic aneurysm market is expanding due to rising incidental detection through CT angiography and echocardiography, enabling earlier diagnosis during routine cardiovascular evaluation. Growing prevalence of hypertension, atherosclerosis, and genetic connective tissue disorders such as Marfan and Loeys-Dietz syndromes is increasing the surveillance population. Rapid adoption of minimally invasive thoracic endovascular aortic repair (TEVAR) is boosting demand for advanced stent graft systems and hybrid operating rooms. Updated clinical guidelines emphasizing aneurysm diameter thresholds and growth-rate monitoring are increasing elective intervention rates in tertiary hospitals. Integration of AI-based imaging analytics for rupture risk prediction and follow-up optimization is improving treatment planning. Favorable reimbursement structures and rising healthcare spending are further supporting adoption of premium endovascular devices and long-term imaging surveillance programs, collectively strengthening market growth across global integrated healthcare systems.

Thoracic Aortic Aneurysm Market Segmentation Analysis

By Treatment Type

The open surgical repair segment is expected to grow at a CAGR of 9.46% during the forecast period, as it offers durable long-term outcomes compared to endovascular options. Increased incidence of complex arch aneurysms requiring extensive reconstruction procedures further drives utilization. Limited long-term durability concerns of TEVAR in certain anatomies encourage surgeons in tertiary centers to continue preferring open repair, especially in cases involving connective tissue disorders and reoperative aortic surgeries requiring direct visualization and graft replacement.

The thoracic endovascular aneurysm repair segment is expected to grow at a CAGR of 10.04% during the forecast period, fueled by rising preference for minimally invasive procedures with lower mortality and faster recovery. Adoption of advanced branched and fenestrated stent grafts, expansion of hybrid operating rooms, and strong clinical outcomes are further driving procedural uptake in high-risk patients.

Request Customizationto receive a tailored report.

By End Use

By end use, hospitals accounted for a share of 72.21% in 2025 due to centralized availability of hybrid operating rooms enabling complex TEVAR procedures. High patient inflow for acute aortic emergencies and elective aneurysm repairs further supports utilization. Additionally, strong presence of multidisciplinary vascular teams and advanced imaging infrastructure enhances procedural accuracy and post-operative monitoring.

The ambulatory surgery centers segment is expected to have the fastest growth in the thoracic aortic aneurysm market, by end use, registering a CAGR of 11.05% during the forecast period. This growth is driven by rising preference for cost-efficient outpatient TEVAR procedures with reduced hospital stay. Increasing adoption of minimally invasive aortic interventions in day-care settings, availability of portable imaging systems, and quicker patient turnaround times are further driving procedure shift from hospitals to ASCs, especially in stable elective thoracic aneurysm cases globally.

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America: Market Leadership through High Adoption of Advanced Aortic Registries and TEVAR by Major Market Players

The North America thoracic aortic aneurysm market share was 44.23% in 2025 due to high adoption of advanced aortic registries and integrated vascular surveillance systems across the US is a key driver, enabling early identification and longitudinal tracking of thoracic aneurysms. Strong presence of hybrid operating rooms in leading cardiac centers supports complex TEVAR procedures. Favorable CMS reimbursement policies for endovascular repair and imaging follow-up encourage higher procedural volumes, reinforcing North America’s dominance in advanced aortic disease management and device utilization.

The US thoracic aortic aneurysm market is growing due to strong presence of leading players such as Medtronic, Cook Medical, and W. L. Gore is driving rapid adoption of advanced TEVAR and branched stent graft technologies in the US. Growth is further supported by high utilization of specialized high-volume aortic centers, widespread incidental detection through CT angiography, and strong CMS reimbursement policies covering endovascular repair and post-procedural imaging surveillance programs.

Canada’s thoracic aortic aneurysm market is driven by centralized care in tertiary cardiac centers like Toronto General Hospital, enabling high adoption of TEVAR for complex arch repairs. Strong provincial health coverage under OHIP supports endovascular procedures and imaging follow-ups. Structured aortic surveillance programs in patients with bicuspid aortic valve and genetic disorders improve early detection and procedural planning across integrated hospital networks.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific: Fastest Growth Driven by Rising Prevalence of Hypertension and Scale-up of National Screening Programs

The Asia Pacific thoracic aortic aneurysm market is expected to register the fastest growth with a CAGR of 12.40% during the forecast period, due to rising prevalence of uncontrolled hypertension and smoking-related aortic degeneration across China, India, and Southeast Asia. Growth is further driven by increasing adoption of hybrid cardiovascular centers in Japan and South Korea, enabling complex TEVAR procedures. Expanding government-led cardiovascular screening programs, such as China’s “Healthy China 2030” initiative, and improving access to CT angiography in tier-2 hospitals are significantly boosting early diagnosis and treatment rates across the region.

China’s thoracic aortic aneurysm market expansion is driven by rapid scale-up of national chest CT screening programs integrated into routine physical examinations, leading to higher incidental aneurysm detection in urban hospitals. Growth is further driven by concentration of advanced TEVAR procedures in top-tier “Grade 3A” hospitals like Fuwai Hospital, Beijing, and strong domestic stent graft manufacturing by companies such as MicroPort. Additionally, aging population with high hypertension prevalence is increasing high-risk patient identification across provincial cardiac networks.

Highly centralized cardiovascular care in university hospitals such as Tokyo University Hospital and Sakakibara Heart Institute enable high adoption of advanced TEVAR procedures, driving the Japan thoracic aortic aneurysm market. Strong national health insurance coverage ensures reimbursement for endovascular repair and lifelong imaging follow-up. Japan’s aging population with high prevalence of hypertension and routine use of CT-based health screening significantly increases early detection and elective intervention rates across specialized vascular centers.

Competitive Landscape

The thoracic aortic aneurysm market is highly consolidated, with a few global medical device companies dominating advanced endovascular repair solutions. Major players such as Medtronic, W. L. Gore & Associates, Cook Medical, Terumo Corporation, and MicroPort focus on thoracic endovascular aortic repair (TEVAR) stent graft systems and complex arch repair technologies. Competition is driven by innovation in branched and fenestrated grafts, physician training programs, and clinical trial evidence. High regulatory requirements and technical complexity create strong entry barriers, reinforcing the leadership of established cardiovascular device manufacturers in this specialized market.

List of Key and Emerging Players in Thoracic Aortic Aneurysm Market